A Phase 2/3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MK-4482 in Hospitalized Adults With COVID-19

Investigator: Daniela Moran, MD

Study Coordinator:

Status: Open Not Enrolling

ClinicalTrials.gov Number: NCT04575584

Phone:

Protocol Number: PRO00028022

Description

Treatment
More to Explore